Found 42 matching trials
Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14 PHASE3 Summary
In patients with prostate cancer (PC) who have only biochemically ...
Show More Location
Copenhagen University hospital, Rigshospitalet
Learn More & Join Trial
Docetaxel or Abiraterone Acetate With ADT in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer PHASE2 This phase II trial studies how well docetaxel or abiraterone acetate work ...
Show More Location
Huntsman Cancer Institute/University of Utah
Learn More & Join Trial
Oral Docetaxel (ModraDoc/r) in Combination With Hormonal Treatment and Radiation Therapy in High-risk Prostate Cancer PHASE1 The optimal treatment for HRPC patients has not yet been established. Recen...
Show More Location
Netherlands Cancer Institute
Learn More & Join Trial
A Study Called AWARENESS Using Data From Men in Alberta to Observe Treatment Patterns for Metastatic Castration-sensitive Prostate Cancer N/A This is an observational study in which patient data from the past on men w...
Show More Learn More & Join Trial
A Trial Comparing Docetaxel 75 mg/m2 (3w) Versus Docetaxel 50 mg/m2 (2w) in Combination With Darolutamide + ADT in mHSPC Patients PHASE3 The purpose of this clinical phase 3 randomized trial is to compare two dif...
Show More Status
Active Not Recruiting
Location
Ordensklinikum Linz GmbH, Elisabethinen
Learn More & Join Trial
Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate Cancer PHASE2 This phase II trial studies how well the combination of apalutamide, abirat...
Show More Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer PHASE2 This is a prospective, open-label, multi-center seamless phase II to phase ...
Show More Location
VA Long Beach Healthcare System, Long Beach, CA
Learn More & Join Trial
Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer PHASE3 RATIONALE: Androgens can cause the growth of prostate cancer cells. Antihor...
Show More Location
Tom Baker Cancer Centre
Learn More & Join Trial
ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable) PHASE3 This is a Phase III, international, multicentre, randomised, double-blinded...
Show More Location
Grand Hopital de Charleroi - site Notre Dame
Learn More & Join Trial
A Trial of Immunotherapy Strategies in Metastatic Hormone-sensitive Prostate Cancer PHASE2 Metastatic prostate cancer is an incurable disease that typically spreads b...
Show More Location
Hospital Son Llatzer
Learn More & Join Trial